metoclopramide tardive dyskinesia|metoclopramide side effects|fda metoclopramide warning|metoclopramide lawsuit|Talk to Lawyer
Latest Posts
Archive

Subscribe to this blog's feed
Tardive Dyskinesia TD News 
Thursday, 06 August 2009
FDA Warns of Metoclopramide Tardive Dyskinesia Risks

The FDA announced that manufacturers of metoclopramide, a drug used to treat gastrointestinal disorders, must add a boxed warning to their drug labels about the risk of its long-term or high-dose use. Chronic use of metoclopramide has been linked to tardive dyskinesia, which may include involuntary and repetitive movements of the body, even after the drugs are no longer taken.

Current product labeling warns of the risk of tardive dyskinesia with chronic metoclopramide treatment. The development of this condition is directly related to the length of time a patient is taking metoclopramide and the number of doses taken. Those at greatest risk include the elderly, especially older women, and people who have been on the drug for a long time. ( SEE: FDA REGLAN WARNING)

POSTED BY: DW AT 11:41 pm   |  Permalink   |  E-mail this
Metoclopramide Tardive Dyskinesia Information for TD treatment, Tardive Dyskinesia Symptoms, causes and the latest news on Nationwide Metoclopramide Reglan Lawsuits and Metoclopramide Class Action Lawsuit Litigation and Settlements and any news of a FDA Metoclopramide Reglan Recall Talk to Reglan side effects metoclopramide lawyer about filing a metoclopramide lawsuit, metoclopramide Reglan lawsuit , side effects from metoclopramide reglan drug, metoclopramide reglan class action lawsuit and additional metaclopramide tardive dyskinesia warnings concerning Parkinson's Diease like side effects including eye blinking, tongue thrusting, eye blinking, restless foot syndrome, hands, legs, frowns, shaking, facial twitches and grimising face expressions, Call and talk to a lawyer attorney at 1-888-FDA-PILL

_____________________________________________________________________________________________